Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.
Respir Res. 2022 Mar 9;23(1):54. doi: 10.1186/s12931-022-01971-5.
Respir Res. 2022.
PMID: 35264154
Free PMC article.
Clinical Trial.